US Stock MarketDetailed Quotes
ADAP Adaptimmune Therapeutics
- 0.579
- -0.009-1.56%
Close Dec 24 13:00 ET
- 0.590
- +0.011+1.94%
Post 17:01 ET
148.11MMarket Cap-3.47P/E (TTM)
0.590High0.575Low1.20MVolume0.581Open0.588Pre Close697.81KTurnover0.69%Turnover RatioLossP/E (Static)255.88MShares2.05052wk High1.85P/B100.63MFloat Cap0.55152wk Low--Dividend TTM173.86MShs Float21.570Historical High--Div YieldTTM2.53%Amplitude0.420Historical Low0.582Avg Price1Lot Size
Adaptimmune Therapeutics Stock Analyst Ratings & Price Target
Price Target
Updated: Dec 25, 2024
The average Adaptimmune Therapeutics stock price target is 2.91 with a max estimate of 3.50 and a min estimate of 2.00
Review Adaptimmune Therapeutics earnings estimates
Detailed Ratings
Receive timely notifications of rating changes
View more detailed ratings of institutions and analysts
View rating details page for historical data
Download APP
Analyst Ratings Disclaimer
Analysis
Price Target
Updated: Dec 25, 2024
Heat List
US
Overall
Symbol
Price
% Chg
No Data
